Previous reports have proposed that general changes in pre-mRNA splicing as a result of p210BCR/ABL kinase activity may contribute to CML pathogenesis [43]; however the mechanisms promoting abnormal RNA processing in CML remain to be elucidated. The gene discussed is ABL1; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.